Kayt Leonard is a Global Health Care and Life Sciences Strategic Advisor at SAS, and leads Market Strategy and Engagement within the Health Care and Life Sciences Practice. Prior to joining SAS, Leonard worked across the industry with payers, providers, physicians, and pharmaceutical organizations. Leonard’s research in health equity, disparities, and global health care access has been recognized by the World Health Organization, the Centers for Disease Control, the Food and Drug Administration, and the European Medicines Agency.
Another promise of innovation and advancement? Not in 2025. The hype of market disruption and transformation might be the content that catches attention, but it’s not always the most accurate description of the industry. For far too long, industry experts have praised the ideas of future-forward growth and promised year-over-year
“Generative AI is essentially just a subcategory of AI; it’s not that new algorithms have been invented.” Marinela Profi, AI Product Strategy Lead at SAS, says it up front and directly in her most recent podcast interview. “It takes a variety of data points, code, images and then, based on
The health care and life sciences market is accelerating – but not without a few necessary pitstops. Machine learning, digital twins, generative AI, robots as doctors, medications with sensors, and surgery at the speed of light. It’s all driving the market. Year after year, market researchers, analyst firms, and industry
When you think about life-saving technology, does a statistical computing environment come to mind? Statistical computing environments (SCE) are critical in accelerating scientific discoveries by enabling researchers to manage, process and analyze data efficiently and compliantly, maintaining the utmost regulatory integrity. As life sciences research generates increasingly large and diverse
